Fundamental Analysis of Metropolis Healthcare Ltd

About the Company - Metropolis Healthcare Ltd

Metropolis Healthcare Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L73100MH2000PLC192798 and registration number is 192798. Currently Company is involved in the business activities of Activities of independent diagnostic/pathological laboratories. Company’s Total Operating Revenue is Rs. 1117.13 Cr. and Equity Capital is Rs. 10.23 Cr. for the Year ended 31/03/2022.

INDUSTRY	ADDRESS	CONTACT
Hospitals & Medical Services	No.250, D Udyog Bhavan, Mumbai Maharashtra 400030	investor.relations@metropolisindia.com http://www.metropolisindia.com

Management
Name	Position Held
Dr. Sushil Kanubhai Shah	Chairman & Executive Director
Mrs. Ameera Sushil Shah	Managing Director
Mr. Hemant Sachdev	Non Exe.Non Ind.Director
Mr. Vivek Gambhir	Ind. Non-Executive Director
Mr. Sanjay Bhatnagar	Ind. Non-Executive Director
Mr. Milind Shripad Sarwate	Ind. Non-Executive Director
Ms. Anita Ramachandran	Ind. Non-Executive Director

Basic Stock Data of Metropolis Healthcare Ltd

Last Updated: July 6, 2024, 11:50 am

Market Cap	10,440 Cr.
Current Price	2,038
High / Low	2,109/1,296
Stock P/E	81.7
Book Value	214
Dividend Yield	0.39 %
ROCE	15.4 %
ROE	12.3 %
Face Value	2.00
PEG Ratio	117.06

Competitors of Metropolis Healthcare Ltd

Stock Name	Market Cap	Current Price	High / Low	Stock P/E	Book Value	Dividend Yield	ROCE	ROE	Face Value
Aspira Pathlab & Diagnostics Ltd	32.1 Cr.	31.2	49.5/25.0		9.85	0.00 %	13.2 %	29.7 %	10.0
Dr Lal Pathlabs Ltd	24,084 Cr.	2,885	2,934/1,943	67.3	222	0.83 %	25.2 %	20.4 %	10.0
Apollo Hospitals Enterprise Ltd	90,995 Cr.	6,329	6,874/4,726	101	482	0.25 %	15.6 %	13.7 %	5.00
Sakar Healthcare Ltd	691 Cr.	318	479/236	59.2	121	0.00 %	7.53 %	5.36 %	10.0
Aster DM Healthcare Ltd	16,988 Cr.	340	558/294	136	91.3	0.59 %	4.28 %	2.90 %	10.0
Industry Average	16,041.39 Cr	836.44		48.68	94.05	0.40%	11.31%	10.45%	9.13

Metropolis Healthcare Ltd Quarterly Results

Month	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Sales	275	292	327	303	293	306	280	300	285	283	277	308	291
Expenses	188	195	224	212	218	231	211	221	215	212	214	234	226
Operating Profit	87	96	102	90	75	75	68	79	70	70	63	75	65
OPM %	32%	33%	31%	30%	26%	24%	24%	26%	25%	25%	23%	24%	22%
Other Income	4	2	20	6	3	6	3	4	7	1	3	1	2
Interest	2	3	6	3	5	6	8	7	6	6	6	6	5
Depreciation	11	14	13	15	17	18	21	22	23	23	21	22	25
Profit before tax	78	82	103	78	56	56	43	55	48	42	39	48	37
Tax %	25%	25%	27%	25%	27%	29%	22%	26%	25%	20%	26%	26%	26%
Net Profit	59	61	75	58	41	40	34	40	36	33	29	36	27
EPS in Rs	11.46	12.00	14.65	11.39	8.02	7.81	6.53	7.88	6.99	6.51	5.62	6.92	5.30

Last Updated: June 4, 2024, 11:26 am

Metropolis Healthcare Ltd Quarterly Chart

Metropolis Healthcare Ltd Profit & Loss

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Sales	388	456	475	545	647	761	856	998	1,228	1,148	1,154
Expenses	285	339	359	405	467	559	619	708	880	855	875
Operating Profit	104	117	116	140	181	203	237	290	348	293	279
OPM %	27%	26%	24%	26%	28%	27%	28%	29%	28%	26%	24%
Other Income	10	7	29	39	6	8	-17	12	34	15	12
Interest	3	2	2	2	4	4	13	12	25	32	24
Depreciation	16	21	17	17	19	20	39	46	63	89	90
Profit before tax	95	101	128	160	164	187	169	244	293	188	177
Tax %	34%	33%	36%	33%	32%	34%	24%	25%	27%	24%
Net Profit	63	68	82	107	112	124	128	183	215	143	134
EPS in Rs	57.34	61.82	80.47	106.52	109.23	23.94	25.15	35.82	41.85	27.90	26.04
Dividend Payout %	2%	0%	100%	49%	0%	55%	32%	22%	19%	29%

Metropolis Healthcare Ltd Profit & Loss Yearly Chart

Growth

Compounded Sales Growth
10 Years:	12%
5 Years:	10%
3 Years:	7%
TTM:	5%

Compounded Profit Growth
10 Years:	9%
5 Years:	2%
3 Years:	-11%
TTM:	-11%

Stock Price CAGR
10 Years:	%
5 Years:	15%
3 Years:	-11%
1 Year:	42%

Return on Equity
10 Years:	22%
5 Years:	21%
3 Years:	17%
Last Year:	12%

Last Updated: June 17, 2024, 2:53 pm

Metropolis Healthcare Ltd Balance Sheet

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Sep 2023
Equity Capital	10	10	10	10	10	10	10	10	10	10	10
Reserves	292	352	269	314	405	408	513	696	876	978	1,036
Borrowings	20	14	5	1	1	18	67	112	379	266	231
Other Liabilities	69	87	107	188	110	113	160	181	256	240	232
Total Liabilities	391	462	391	512	526	550	750	1,000	1,521	1,495	1,509
Fixed Assets	149	153	142	202	207	213	296	343	1,059	1,121	1,148
CWIP	1	0	1	1	0	6	3	0	6	20	0
Investments	132	168	101	142	102	33	14	10	16	15	38
Other Assets	109	141	147	167	216	298	437	647	440	340	323
Total Assets	391	462	391	512	526	550	750	1,000	1,521	1,495	1,509

Metropolis Healthcare Ltd Reserves and Borrowings Chart

Metropolis Healthcare Ltd Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity	77	69	91	102	104	90	215	249	253	247
Cash from Investing Activity	-61	-56	96	-86	1	36	-104	63	-736	48
Cash from Financing Activity	-14	-9	-174	-17	-87	-118	-55	-33	163	-292
Net Cash Flow	2	4	14	-1	18	8	56	279	-321	3

Metropolis Healthcare Ltd Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	47	57	54	54	57	66	55	45	40	39	38
Inventory Days	47	52	46	38	53	55	44	59	68	64	58
Days Payable	75	92	96	97	88	90	152	160	136	136	150
Cash Conversion Cycle	19	17	3	-5	21	30	-54	-56	-29	-33	-53
Working Capital Days	22	32	8	-27	28	42	11	4	14	14	23
ROCE %		28%	34%	46%	43%	43%	40%	36%	29%	17%

Metropolis Healthcare Ltd Financial Efficiency Indicators Chart

Metropolis Healthcare Ltd Share Holding Pattern

Month	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoters	50.37%	50.33%	49.50%	49.79%	49.79%	49.76%	49.76%	49.75%	49.75%	49.75%	49.74%	49.67%
FIIs	28.59%	30.72%	30.06%	21.91%	23.20%	25.57%	23.86%	25.67%	25.66%	24.29%	21.66%	18.90%
DIIs	14.59%	12.26%	11.35%	16.20%	14.50%	12.38%	13.30%	13.64%	14.89%	16.86%	20.73%	24.86%
Public	6.45%	6.69%	9.09%	12.11%	12.52%	12.30%	13.09%	10.94%	9.69%	9.10%	7.87%	6.57%
No. of Shareholders	33,527	43,552	64,168	79,895	86,404	90,090	91,452	84,269	89,692	86,249	79,878	68,283

Metropolis Healthcare Ltd Shareholding Pattern Chart

No. of Metropolis Healthcare Ltd Shareholders

Metropolis Healthcare Ltd Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Nippon India Small Cap Fund	1,085,411	0.45	184.86	218,838	2024-07-05	395.99%
UTI Flexi Cap Fund	804,230	0.54	136.97	218,838	2024-07-05	267.5%
Franklin India Smaller Companies Fund	715,459	1.13	121.85	218,838	2024-07-05	226.94%
UTI Large Cap Fund	617,518	0.9	105.17	218,838	2024-07-05	182.18%
UTI Value Fund	550,000	1.17	93.67	218,838	2024-07-05	151.33%
Aditya Birla Sun Life Flexi Cap Fund	506,015	0.48	86.18	218,838	2024-07-05	131.23%
UTI Mid Cap Fund	418,897	0.76	71.34	218,838	2024-07-05	91.42%
Quant Small Cap Fund	359,668	0.55	61.26	218,838	2024-07-05	64.35%
UTI ELSS Tax Saver Fund	237,442	1.22	40.44	218,838	2024-07-05	8.5%
UTI Small Cap Fund	218,838	1.08	37.27	218,838	2024-07-05	0%

Metropolis Healthcare Ltd ROCE Trend

Metropolis Healthcare Ltd EPS Trend

Metropolis Healthcare Ltd Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	2.00	2.00	2.00	2.00	2.00
Basic EPS (Rs.)	24.95	27.91	41.87	35.97	25.36
Diluted EPS (Rs.)	24.87	27.91	41.66	35.79	25.25
Cash EPS (Rs.)	43.52	45.42	54.31	44.86	33.05
Book Value[Excl.RevalReserv]/Share (Rs.)	214.59	193.46	173.56	138.52	103.72
Book Value[Incl.RevalReserv]/Share (Rs.)	214.59	193.46	173.56	138.52	103.72
Revenue From Operations / Share (Rs.)	235.76	224.21	240.04	195.24	169.15
PBDIT / Share (Rs.)	56.94	59.27	70.43	58.31	47.68
PBIT / Share (Rs.)	38.50	41.85	58.08	49.32	39.92
PBT / Share (Rs.)	34.10	36.61	57.33	47.80	33.43
Net Profit / Share (Rs.)	25.08	28.00	41.95	35.87	25.30
NP After MI And SOA / Share (Rs.)	24.95	27.90	41.86	35.82	25.15
PBDIT Margin (%)	24.15	26.43	29.34	29.86	28.18
PBIT Margin (%)	16.33	18.66	24.19	25.26	23.60
PBT Margin (%)	14.46	16.33	23.88	24.48	19.76
Net Profit Margin (%)	10.63	12.48	17.47	18.37	14.95
NP After MI And SOA Margin (%)	10.58	12.44	17.43	18.34	14.86
Return on Networth / Equity (%)	11.66	14.45	24.11	25.91	24.32
Return on Capital Employeed (%)	15.06	17.32	24.18	31.49	34.68
Return On Assets (%)	8.21	9.51	13.99	18.22	16.92
Long Term Debt / Equity (X)	0.00	0.02	0.17	0.00	0.00
Total Debt / Equity (X)	0.00	0.07	0.29	0.00	0.00
Asset Turnover Ratio (%)	0.79	0.71	0.95	0.96	1.07
Current Ratio (X)	1.28	1.14	1.30	2.98	2.34
Quick Ratio (X)	1.13	0.97	1.13	2.78	2.20
Inventory Turnover Ratio (X)	5.83	0.00	0.00	0.00	0.00
Dividend Payout Ratio (NP) (%)	0.00	28.67	19.11	22.33	31.52
Dividend Payout Ratio (CP) (%)	0.00	17.65	14.75	17.85	24.09
Earning Retention Ratio (%)	0.00	71.33	80.89	77.67	68.48
Cash Earning Retention Ratio (%)	0.00	82.35	85.25	82.15	75.91
Interest Coverage Ratio (X)	12.94	11.32	18.26	38.30	28.93
Interest Coverage Ratio (Post Tax) (X)	6.70	6.35	11.07	24.56	19.29
Enterprise Value (Cr.)	8775.73	6384.27	10513.81	11037.23	6303.53
EV / Net Operating Revenue (X)	7.27	5.56	8.56	11.06	7.36
EV / EBITDA (X)	30.09	21.03	29.17	37.03	26.11
MarketCap / Net Operating Revenue (X)	7.32	5.57	8.48	11.48	7.60
Retention Ratios (%)	0.00	71.32	80.88	77.66	68.47
Price / BV (X)	8.07	6.47	11.73	16.21	12.44
Price / Net Operating Revenue (X)	7.32	5.57	8.48	11.48	7.60
EarningsYield	0.01	0.02	0.02	0.01	0.01

Metropolis Healthcare Ltd Profitability Ratios (%)

Metropolis Healthcare Ltd Liquidity Ratios

Metropolis Healthcare Ltd Liquidity Ratios (%)

Metropolis Healthcare Ltd Interest Coverage Ratios (%)

Metropolis Healthcare Ltd Valuation Ratios

Fair Value

Fair Value: 2,158.89

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 5.93% compared to the current price 2038

Intrinsic Value: 2,173.96

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 6.67% compared to the current price ₹2038

Last 5 Year EPS CAGR: 0.70%

*Investments are subject to market risks

Strength and Weakness of Metropolis Healthcare Ltd Stock

Strength	Weakness
The stock has a high average ROCE of 28.73%, which is a positive sign. The stock has a low average Working Capital Days of 15.55, which is a positive sign. The stock has a low average Cash Conversion Cycle of -12.73, which is a positive sign. The company has higher reserves (558.09 cr) compared to borrowings (101.27 cr), indicating strong financial stability. The company has shown consistent growth in sales (466.27 cr) and profit (173.27 cr) over the years.

Strength

Weakness

The stock has a high average ROCE of 28.73%, which is a positive sign.
The stock has a low average Working Capital Days of 15.55, which is a positive sign.
The stock has a low average Cash Conversion Cycle of -12.73, which is a positive sign.
The company has higher reserves (558.09 cr) compared to borrowings (101.27 cr), indicating strong financial stability.
The company has shown consistent growth in sales (466.27 cr) and profit (173.27 cr) over the years.

FAQ

What is the latest fair value of Metropolis Healthcare Ltd?

The latest fair value of Metropolis Healthcare Ltd is ₹2158.89.

What is the Market Cap of Metropolis Healthcare Ltd?

The Market Cap of Metropolis Healthcare Ltd is 10,440 Cr..

What is the current Stock Price of Metropolis Healthcare Ltd as on 06 July 2024?

The current stock price of Metropolis Healthcare Ltd as on 06 July 2024 is 2,038.

What is the High / Low of Metropolis Healthcare Ltd stocks in FY 2024?

In FY 2024, the High / Low of Metropolis Healthcare Ltd stocks is 2,109/1,296.

What is the Stock P/E of Metropolis Healthcare Ltd?

The Stock P/E of Metropolis Healthcare Ltd is 81.7.

What is the Book Value of Metropolis Healthcare Ltd?

The Book Value of Metropolis Healthcare Ltd is 214.

What is the Dividend Yield of Metropolis Healthcare Ltd?

The Dividend Yield of Metropolis Healthcare Ltd is 0.39 %.

What is the ROCE of Metropolis Healthcare Ltd?

The ROCE of Metropolis Healthcare Ltd is 15.4 %.

What is the ROE of Metropolis Healthcare Ltd?

The ROE of Metropolis Healthcare Ltd is 12.3 %.

What is the Face Value of Metropolis Healthcare Ltd?

The Face Value of Metropolis Healthcare Ltd is 2.00.